• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 CRISPR 的基因必需性测试方法。

A CRISPR-based method for testing the essentiality of a gene.

机构信息

Chemotaxis Signal Section, Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD, USA.

出版信息

Sci Rep. 2020 Sep 8;10(1):14779. doi: 10.1038/s41598-020-71690-8.

DOI:10.1038/s41598-020-71690-8
PMID:32901070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7478968/
Abstract

The CRISPR/Cas9 system is a powerful method of editing genes by randomly introducing errors into the target sites. Here, we describe a CRISPR-based test for gene essentiality (CRISPR-E test) that allows the identification of essential genes. Specifically, we use sgRNA-mediated CRISPR/Cas9 to target the open reading frame of a gene in the genome and analyze the in-frame (3n) and frameshift (3n + 1 and 3n + 2) mutations in the targeted region of the gene in surviving cells. If the gene is non-essential, the cells would carry both in-frame (3n) and frameshift (3n + 1 and 3n + 2) mutations. In contrast, the cells would carry only in-frame (3n) mutations if the targeted gene is essential, and this selective elimination of frameshift (3n + 1 and 3n + 2) mutations of the gene indicate its essentiality. As a proof of concept, we have used this CRISPR-E test in the model organism Dictyostelium discoideum to demonstrate that Dync1li1 is an essential gene while KIF1A and fAR1 are not. We further propose a simple method for quantifying the essentiality of a gene using the CRISPR-E test.

摘要

CRISPR/Cas9 系统是一种通过随机在靶位点引入错误来编辑基因的强大方法。在这里,我们描述了一种基于 CRISPR 的基因必需性测试(CRISPR-E 测试),该测试可用于鉴定必需基因。具体来说,我们使用 sgRNA 介导的 CRISPR/Cas9 靶向基因组中基因的开放阅读框,并分析靶基因区域中存活细胞的框架内(3n)和移码(3n+1 和 3n+2)突变。如果基因是非必需的,那么细胞将同时携带框架内(3n)和移码(3n+1 和 3n+2)突变。相比之下,如果靶基因是必需的,那么细胞将仅携带框架内(3n)突变,这种对基因的移码(3n+1 和 3n+2)突变的选择性消除表明其必需性。作为概念验证,我们已经在模式生物盘基网柄菌中使用这种 CRISPR-E 测试证明了 Dync1li1 是一个必需基因,而 KIF1A 和 fAR1 则不是。我们进一步提出了一种使用 CRISPR-E 测试量化基因必需性的简单方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/7587ce816424/41598_2020_71690_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/55b32f2d5a85/41598_2020_71690_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/453d066bf089/41598_2020_71690_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/0a82658e2a39/41598_2020_71690_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/7587ce816424/41598_2020_71690_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/55b32f2d5a85/41598_2020_71690_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/453d066bf089/41598_2020_71690_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/0a82658e2a39/41598_2020_71690_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/7478968/7587ce816424/41598_2020_71690_Fig4_HTML.jpg

相似文献

1
A CRISPR-based method for testing the essentiality of a gene.基于 CRISPR 的基因必需性测试方法。
Sci Rep. 2020 Sep 8;10(1):14779. doi: 10.1038/s41598-020-71690-8.
2
CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium.CRISPR/Cas9 介导的粘菌中多个基因的靶向。
Sci Rep. 2018 May 31;8(1):8471. doi: 10.1038/s41598-018-26756-z.
3
Recent Advances in CRISPR/Cas9-Mediated Genome Editing in .CRISPR/Cas9 介导的基因组编辑在 中的最新进展。
Cells. 2019 Jan 12;8(1):46. doi: 10.3390/cells8010046.
4
Harnessing accurate non-homologous end joining for efficient precise deletion in CRISPR/Cas9-mediated genome editing.利用精确的非同源末端连接实现 CRISPR/Cas9 介导的基因组编辑中的高效精确缺失。
Genome Biol. 2018 Oct 19;19(1):170. doi: 10.1186/s13059-018-1518-x.
5
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
6
Discovery of rice essential genes by characterizing a CRISPR-edited mutation of closely related rice MAP kinase genes.通过对密切相关的水稻促分裂原活化蛋白激酶基因的CRISPR编辑突变进行表征来发现水稻必需基因。
Plant J. 2017 Feb;89(3):636-648. doi: 10.1111/tpj.13399. Epub 2017 Feb 1.
7
Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.利用 CRISPR-Cas9 高效进行烈性肺炎克雷伯氏菌噬菌体的基因组工程改造。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00534-18. Print 2018 Sep 1.
8
Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.支架介导的非病毒递送平台用于基于 CRISPR/Cas9 的基因组编辑。
Acta Biomater. 2019 May;90:60-70. doi: 10.1016/j.actbio.2019.04.020. Epub 2019 Apr 9.
9
CRISPR/Cas9-Based Genome Editing Toolbox for Arabidopsis thaliana.基于 CRISPR/Cas9 的拟南芥基因组编辑工具包。
Methods Mol Biol. 2021;2200:121-146. doi: 10.1007/978-1-0716-0880-7_5.
10
Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting.无监督校正基因独立的 CRISPR-Cas9 靶向细胞反应。
BMC Genomics. 2018 Aug 13;19(1):604. doi: 10.1186/s12864-018-4989-y.

引用本文的文献

1
Comparison of CRISPR-MAD7 and CRISPR-Cas9 for Gene Disruptions in .CRISPR-MAD7与CRISPR-Cas9在[具体对象]中进行基因破坏的比较 。 (你原文中“in.”后面缺少具体内容)
J Fungi (Basel). 2024 Mar 5;10(3):197. doi: 10.3390/jof10030197.
2
Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit.CRISPR 工具包在干细胞基因组编辑中的研究与治疗方法。
Molecules. 2023 Feb 20;28(4):1982. doi: 10.3390/molecules28041982.
3
Using Structure-guided Fragment-Based Drug Discovery to Target Infections in Cystic Fibrosis.利用基于结构的片段药物发现来靶向囊性纤维化中的感染。

本文引用的文献

1
Massively parallel profiling and predictive modeling of the outcomes of CRISPR/Cas9-mediated double-strand break repair.大规模平行分析和预测 CRISPR/Cas9 介导的双链断裂修复结果的模型。
Nucleic Acids Res. 2019 Sep 5;47(15):7989-8003. doi: 10.1093/nar/gkz487.
2
Minimum Information about an Uncultivated Virus Genome (MIUViG).未培养病毒基因组信息最低要求(MIUViG)。
Nat Biotechnol. 2019 Jan;37(1):29-37. doi: 10.1038/nbt.4306. Epub 2018 Dec 17.
3
Target-Specific Precision of CRISPR-Mediated Genome Editing.CRISPR 介导的基因组编辑的靶向精确性。
Front Mol Biosci. 2022 Mar 30;9:857000. doi: 10.3389/fmolb.2022.857000. eCollection 2022.
4
CRISPR Toolbox for Genome Editing in .用于基因组编辑的CRISPR工具包 于……(原文此处不完整)
Front Cell Dev Biol. 2021 Aug 18;9:721630. doi: 10.3389/fcell.2021.721630. eCollection 2021.
5
Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.利用工程化的近无 PAM Cas9 变体在盘基网柄菌中进行基因敲入和精确的核苷酸替换。
Sci Rep. 2021 May 27;11(1):11163. doi: 10.1038/s41598-021-89546-0.
6
Epstein-Barr Virus Limits the Accumulation of IPO7, an Essential Gene Product.爱泼斯坦-巴尔病毒限制了IPO7(一种必需基因产物)的积累。
Front Microbiol. 2021 Feb 16;12:643327. doi: 10.3389/fmicb.2021.643327. eCollection 2021.
Mol Cell. 2019 Feb 21;73(4):699-713.e6. doi: 10.1016/j.molcel.2018.11.031. Epub 2018 Dec 13.
4
CRISPR/Cas9 mediated targeting of multiple genes in Dictyostelium.CRISPR/Cas9 介导的粘菌中多个基因的靶向。
Sci Rep. 2018 May 31;8(1):8471. doi: 10.1038/s41598-018-26756-z.
5
Human gene essentiality.人类基因的必需性。
Nat Rev Genet. 2018 Jan;19(1):51-62. doi: 10.1038/nrg.2017.75. Epub 2017 Oct 30.
6
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization.基于条件性 Cas9 稳定化的快速且可调谐的基因编辑时间控制方法。
Nat Commun. 2017 Feb 22;8:14370. doi: 10.1038/ncomms14370.
7
DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks.DNA 修复谱分析揭示 Cas9 介导的断裂的非随机结果。
Mol Cell. 2016 Aug 18;63(4):633-646. doi: 10.1016/j.molcel.2016.06.037. Epub 2016 Aug 4.
8
Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes.对用于必需基因的CRISPR/Cas9和RNA干扰筛选进行系统比较。
Nat Biotechnol. 2016 Jun;34(6):634-6. doi: 10.1038/nbt.3567. Epub 2016 May 9.
9
CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes.CRISPR 敲除筛选在鉴定必需基因方面优于 shRNA 和 CRISPRi。
Nat Biotechnol. 2016 Jun;34(6):631-3. doi: 10.1038/nbt.3536. Epub 2016 Apr 25.
10
Identification of a Chemoattractant G-Protein-Coupled Receptor for Folic Acid that Controls Both Chemotaxis and Phagocytosis.鉴定一种控制趋化作用和吞噬作用的叶酸化学引诱物G蛋白偶联受体。
Dev Cell. 2016 Feb 22;36(4):428-39. doi: 10.1016/j.devcel.2016.01.012.